Post by
hydrocarbss on Jun 20, 2020 6:28am
Do the Math
We aren't given the exact breakdown for the Trilogy 1 trial.
So will use approximations.
Trilogy 1 enrolled 242 particpants
121 in the placebo 121 in the Capre
The placebo arm had 36% of participants in the 5 trial sites with issues.
36% of 121 is 43. The other 78 had 'within range' placebo effect, a guess.
The placebo arm showed an overall reduction of 27.5% of triglycerides.
That is the average for all 121. Those 43 must have had huge reduction numbers.
Trial was for people with triglyceride blood levels from 500 mg/dL to 1500 mg/d
Those 43 with the huge reduction
Add 78 with normal placebo response
And the entire group average 27.5% reduction....
Two (of 78) with placebo reduction of 10% would mean one (of 43) in the suspect sites would have to have a 62.5% drop on TG's in order for those three to average a 27.5% reduction...
Crazy mixup...
Comment by
Danny1082Man on Jun 20, 2020 7:35am
I will have to look it up but I thought the number of patients assigned was 2.5:1 for CaPre verses Placebo
Comment by
hydrocarbss on Jun 20, 2020 9:57am
Thanks, did this after staying up all night...
Comment by
lscfa on Jun 20, 2020 9:57am
Does each site maintain the 2.5-to-1 ratio or is that a study wide goal? If study is truly double blinded then ratio may vary from site to site. Did the 5 bad sites have a higher no. of placebo patients than overall goal?
Comment by
Danny1082Man on Jun 20, 2020 1:36pm
2.5:1 is full study. Some sites only have a couple of patients
Comment by
Danny1082Man on Jun 20, 2020 1:38pm
Exact reason why the call on the 29th is so important. How many placebo patients were at the site? Could, we hope, a disproportionate amount were from there, or that will be a huge concern
Comment by
Danny1082Man on Jun 20, 2020 7:37am
And your assumption I believe is wrong. They take the median, not the average of placebo reduction
Comment by
Danny1082Man on Jun 20, 2020 1:45pm
Trilogy 1 would have 175 on CaPre and 70 on placebo. So you would need 36 high placebo out of 248 subjects to torpedo the study. How many of the 35 placebo were at those 5 sites? That's the golden ticket question